BIOVIE INC - CL A NEW (BIVI)

CUSIP: 09074F207

Q3 2022 13F Holders as of 30 Sep 2022

Share change
-620,073
SEC-reported price per share
$2.49
Number of holders
16
Value change
-$1,501,190
Number of buys
8
Number of sells
5

Security key

09074F207

Report period

Q3 2022

Institutions

16

Top holders

10

Ownership snapshot

Top reported holders of BIVI - BIOVIE INC - CL A NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
0/14
Latest evidence
30 Jun 2022
13F 3/4/5 Highest disclosed value: $910,000 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

SABBY MANAGEMENT, LLC has the largest disclosed position value at $910K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.
Disclosed position value Top 5
SABBY MANAGEMENT, LLC $910K
swisspartners Ltd. $241K
VANGUARD GROUP INC $238K
Jonathan M. Adams $82.2K
GEODE CAPITAL MANAGEMENT, LLC $57K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SABBY MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$910,000
627,370 shares
— 30 Jun 2022
swisspartners Ltd.
13F
Company
13F
—
denominator unverified
$241,000
161,000 shares
— 30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$238,000
164,480 shares
— 30 Jun 2022
Jonathan M. Adams
3/4/5
EVP Liver Cirrhosis Programs
—
denominator unverified
$82,185
48,630 shares
— 02 Feb 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$57,000
39,438 shares
— 30 Jun 2022
Kepos Capital LP
13F
Company
13F
—
denominator unverified
$36,000
25,000 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
16
Shares
479,391
Rows available
16
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
13
Q3 2022 holders
16
Holder diff
3
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .